Enero Group Limited · ASX:EGG

Enero — FY2025 Earnings Presentation

23 slides from Enero's earnings presentation, Aug 29, 2025

  1. Slide 1: Enero Group FY25 Results

    x } | , WSs Enero Group FY25 Results 29 August 2025 (4 | free thinkers united

  2. Slide 2: FY25 highlights

    FY25 highlights Tech, Healthcare & Consumer (THC) Practice momentum Revenue and EBITDA‘ growth with improved margins from prior half Strong momentum in BMF with Westpac win in February 2025 largest win in history Orchard delivered strong H2 after challenging start to the year Hotwire completed ROI-D

  3. Slide 3: Continuing operations' improved EBITDA and margin performance

    Continuing operations' improved EBITDA and margin performance in Continuing Operations! (AS'm) Net revenue? 1387 Expenses (124.6) EBITDA! 141 EBITDA margin’ 10.2% Adjusted Net profit” a2 attributable to equity owners “ Adjusted EPS? 46 cents Net profit attributable to 16 equity owners. Earnings per

  4. Slide 4: Improvement in YoY EBITDA and margin driven by reduction in expenses

    Improvement in YoY EBITDA and margin driven by reduction in expenses in T Half-on-half Performance Revenue ----EBITDA H2v H1 68.7 70.1 2% 21% FY25 H1 FY25 H2 i EBITDA margin 9.3% 11.0% | +1.7ppts e. Note: Refer to definitions on slide 21 Continuing Operations! (AS'm) Technology, Healthcare & Consume

  5. Slide 5: THC Practice momentum delivered revenue and EBITDA growth in H2

    THC Practice momentum delivered revenue and EBITDA growth in H2 Half-on-half Performance MRevenue ~-EBITDA H2vH1 68.7 70.1 2% 9% FY25 H1 Fy25 H2 EBITDA ‘ 15.9% 17.1% | +1.2ppts margin e. Net Revenue EBITDA EBITDA Margin FY24 ‘e | FY25 FY24 | FY25 FY24 Hotwire Global 78.6 817 (4%) nN 96 15% 141% 18%

  6. Slide 6: Diversified revenue mix across industry and geos with $1M clients

    Diversified revenue mix across industry and geos with aoe 35 +S1M clients Practice revenue by industry Finance 5% Other \ Services Healthcare Practice revenue by geography Australia & HOTWIRE BMF Practice revenue model Large clients Retainer - Fixed 51% Retainer - Variable 9% Revenue diversified by

  7. Slide 7: Hotwire EBITDA increased YoY despite a challenging market

    Hotwire EBITDA increased YoY despite a challenging HOTWIRE Global market and leadership transition FY25 Performance Half-on-Half Performance Commentary Revenue $78.6m -4% YoY EBITDA St1.1m +15% YoY Margin 141% +2.3ppt YoY MRevenue “EBITDA H2vH1 39.6 38.9 -2% FY25 H1 FY25 H2 EBITDA margin 153% 12.9%

  8. Slide 8: BMF has built momentum in H2 after significant pitching investments

    BMF has built momentum in H2 after significant pitching investments in H1 FY25 Performance Half-on-Half Performance Commentary MRevenue “EBITDA H2vH1 Revenue $34.4m -2% YoY 17.2 17.2 0% EBITDA $6.9m “14% YoY 11% FY25 H1 FY25 H2 EBITDA margin 19.0% 21.2% +2.2ppt + Westpac win in February 2025 was the

  9. Slide 9: Orchard doubled EBITDA in H2 and exits FY25 strongly

    Orchard doubled EBITDA in H2 and exits FY25 strongly } FY25 Performance Half-on-Half Performance Commentary * Management focus on execution delivered an exceptional performance in FY25 H2, Revenue «EBITDA H2vH1 growing revenue and doubling H1 EBITDA Revenue ato * Challenging start to FY25 due to del

  10. Slide 10: Sustained focus on costs delivering benefits in FY25

    Sustained focus on costs delivering benefits in FY25 Expense by segment (ASM, cons curr, continuing ops') Commentary 80 60 40 20 v FY23 H1 61.6 | ] 76.1 1.0 674 «ggg. a 64.7 15 pep 0-6 05 63.0 ; ! FY23H1 FY23H2 FY24H1 FY24H2_FY25 H1 WITHC Practice Corporate Costs IISBP FY25 H2 FY25 H2 -19% 4% -34% -

  11. Slide 11: Key Financial Metrics

    KEY FINANCIAL METRICS

  12. Slide 12: Statutory profit & loss

    Statutory profit & loss or Z Commentary * 3% YoY net revenue decline under challenging Net revenue? 1387 143.5 (3%) . a macroeconomic and technology industry conditions Other income 04 04 * Staff costs ratio* for THC Practice of 72% (FY24: 73%) with Staff costs (108.0) (142) ratio in FY25 H2 71% Ope

  13. Slide 13: Significant items

    Significant items Continuing Operations! (AS'm) Restructuring and other costs Fair value adjustments Impairment loss and reassessment of useful life Loss on sale of business Total significant items before tax Tax expense Significant items, net of tax expense (5.7) (53.1) Commentary * Restructuring a

  14. Slide 14: Healthy cash conversion

    Healthy cash conversion including discontinuin: Commentary EBITDA 262 374 * Cash conversion" at 79% of EBITDA (FY24: 88%) driven Movement in working capital 39 (0.5) by higher restructuring costs and lower gross cash flow Equity incentive expense 12 W due to reduced EBITDA Restructuring and other co

  15. Slide 15: Robust capital position post OBMedia disposal

    Robust capital position post OBMedia disposal Cash Trade and other receivables Other assets Intangible assets Property, plant and equipment Total assets Other current liabilities & provisions Lease liabilities Contingent consideration payable Interest bearing liabilities Other non-current liabilitie

  16. Slide 16: Appendix

    APPENDIX

  17. Slide 17: FY25 Results - Continuing Operations and including Discontinuing Operations

    FY25 Results - Continuing Operations and including Discontinuing Operations Continuing Operations! (AS'm) Net revenue? Expenses EBITDAt EBITDA margin’ Adjusted Net profit” attributable to equity owners Adjusted EPS? Net profit attributable to equity owners Earnings per share (EPS) 1387 (124.6) 141 1

  18. Slide 18: Segment results on an underlying basis

    Segment results on an underlying basis Underlying Results Revenue EBITDA EBITDA Margin (Asim) FY25 FY24 eo FY25 FY24 % FY25 FY24 Change Change Technology, Healthcare & 5 . , Zechnology, Health 1387 1435 (3%) 29 28 02% 165% 159% Corporate Costs - - - (75) (79) 4% 2 : Equity Incentive Expense - - - (1

  19. Slide 19: FY25 Results by Halves - Continuing Operations and including Discontinuing Operations

    FY25 Results by Halves - Continuing Operations and including Discontinuing Operations Continuing Operations (AS'm) Net revenue? Expenses EBITDAt EBITDA margin’ Adjusted Net profit” attributable to equity owners Adjusted EPS? FY25 H1 687 (623) 64 9.3% Ww 12 cents FY25 H2 70: (623) 77 11.0% 3 3.4 cent

  20. Slide 20: Results by Geography

    Results by Geography oes Operations! FY24 | % Change Revenue USA 45.2 465 (3%) Australia and Asia 64.0 66.4 (4%) UK and Europe 296 307 (4%) Total 138.7 143.5 (3%) EBITDA USA 75 44 70% Australia and Asia 122 135 (10%) UK and Europe 32 49 (35%) Total operating companies 22.9 22.8 0.2% Corporate costs

  21. Slide 21: Definitions

    Definitions Continuing operations: excludes OBMedia sold on 30 June 2025 2. Discontinuing operations: OBMedia business, sold on 30 June 2025 3. Net revenue: gross revenue recognised in accordance with AASB 15 less directly attributable cost of sales 4. EBITDA: profit before interest, taxes, deprecia

  22. Slide 22: All content, concepts and ideas contained within this document are private

    All content, concepts and ideas contained within this document are private and confidential. They must not

  23. Slide 23: Disclaimer

    Disclaimer This document has been prepared by Enero Group Limited (Enero) and comprises written materials/slides for a presentation concerning Enero. This is not a prospectus, disclosure document or offering document. This document is for information purposes only and does not constitute or form par

Enero Group — FY2025 Earnings Presentation on 6ix